• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Cornea >Intravenous immunoglobulin therapy for refractory ocular cicatricial pemphigoid: case report.
【24h】

Intravenous immunoglobulin therapy for refractory ocular cicatricial pemphigoid: case report.

机译：静脉免疫球蛋白治疗难治性眼瘢痕性天疱疮：病例报告。

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

PURPOSE: To report the favorable outcome of a patient with severe ocular cicatricial pemphigoid, which was refractory to conventional treatment but recovered after intravenous immunoglobulin therapy. METHODS: A case report. RESULTS: Conventional therapy failed to control the ocular symptoms of this patient, which are typical of the disease. However, the patient improved remarkably in response to pulsed intravenous human immunoglobulin therapy. CONCLUSIONS: We achieved stabilization of the disease around the seventh intravenous immunoglobulin cycle, thus contributing to satisfactory postoperative evolution after limbal allograft transplantation and facilitating the performance of intraocular surgical procedures, such as phacoemulsification, with improvement in best-corrected visual acuity.
机译：目的：报告重度眼瘢痕类天疱疮患者的良好疗效，该患者对常规治疗无效，但经静脉免疫球蛋白治疗后可恢复。方法：病例报告。结果：常规治疗未能控制该患者的典型眼病症状。但是，患者对脉冲静脉内人免疫球蛋白疗法的反应明显改善。结论：我们在第七个静脉内免疫球蛋白周期左右实现了疾病的稳定，从而为同种异体角膜缘缘移植术后的令人满意的术后发展做出了贡献，并促进了眼内外科手术（如超声乳化）的性能，并改善了最佳矫正视力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号